First evidence of native dendritic cells in brain

In a finding that has the potential to change the way researchers think about the brain, scientists at Rockefeller University have found dendritic cells where they’ve never been seen before: among this organ’s neurons and connective cells.

The immunity-directing dendritic cell had previously been seen in the human nervous system only after brain injury or disease. But the new study, published next month in the Journal of Comparative Neurology, shows for the first time that the brain has its own, resident population of dendritic cells that may serve as a line of defense against pathogens that sneak past the blood-brain barrier.

The brain is packed with different types of microglia — cells that perform a variety of immune functions in the central nervous system. Until now, however, no one had identified dendritic cells among them. Research associate professor Karen Bulloch and her colleagues made their discovery using mice bred to have a fluorescent marker attached to a dendritic-cell specific protein.

Originally developed by Rockefeller scientists to help them visualize dendritic cells in immune tissues, Bulloch reasoned that the mice might be helpful in determining whether dendritic cells are also in the central nervous system. Bulloch, who’s spent a lot of time studying microglia, knew exactly where in the brain to look. But what she saw when she first peered through the microscope surprised her so much, she says, “I literally almost fell off my chair.”

Once they had confirmed that the brain seems to develop its own population of dendritic cells, the researchers, with the help of graduate student Melinda Miller, mapped the cells’ locations. “They ended up in places I just didn’t understand,” Bulloch says. So she did a bit of digging and discovered that the protective dendritic cells appeared in areas of the brain associated with postnatal neuron formation, as well as along nasal-associated pathways through which viruses, bacteria and toxic chemicals can gain direct access to the brain. “The dendritic cells serve both as shepherds of newborn nerve cells and as gatekeepers, which police intruding molecules that may come into the brain through these pathways.”

The discovery that some dendritic cells that are native to the brain, rather than just infiltrating during traumatic events, comes with a wide range of implications. “Their location suggests a multiplicity of functions, ranging from surveillance to participation in a number of events in the brain,” says Bruce McEwen, Alfred E. Mirsky Professor and head of the Harold and Margaret Milliken Hatch Laboratory of Neuroendocrinology, where the work was conducted. But their position might also be an important factor to consider when evaluating drug administration, since certain vaccines and medications are now given nasally.

“In a way, it’s reassuring that there are cells there monitoring for invaders. On the other hand, it raises questions about the wisdom of that vaccine approach in the first place. The degree to which these drug molecules might alter the immune system of the brain is unknown,” McEwen says.

Citation: The Journal of Comparative Neurology 508(5): 687-710 (June 10, 2008)

Source: Rockefeller University

Related stories:

Arteries from distinct regions of the body have unique immune functions
Human arteries play distinct roles in the immune system depending on their anatomical location, researchers at Emory University School of Medicine have discovered.
The first autism disease genes
The autistic disorder was first described, more than sixty years ago, by Dr. Leo Kanner of the Johns Hopkins Hospital (USA), who created the new label 'early infantile autism'. At the same time an Austrian scientist, Dr. Hans Asperger, described a milder form of the disorder that became known as Asperger Syndrome, characterised by higher cognitive abilities and more normal language function. Today, both disorders are classified in the continuum of 'Pervasive Developmental Disorders' (PDD), more often referred to as Autism Spectrum Disorders (ASD).
Scientists' findings may lead to new drug-abuse treatments
Increased connections among brain cells caused by excessive drug use may represent the body's defense mechanism to combat addiction and related behaviors, scientists at UT Southwestern Medical Center have found.
Cocaine-induced brain plasticity may protect the addicted brain
A new study has unraveled some of the mysteries of the cocaine-addicted brain and may pave the way for the design of more effective treatments for drug addiction. The research, published by Cell Press in the August 28 issue of the journal Neuron, identifies specific brain mechanisms that underlie addiction-related structural changes in the brain and provides surprising insight into how these changes may actually defend the brain during excessive drug use.
Efficient technique enables thinking
(PhysOrg.com) -- Nerve cells constantly create new contact points to their neighbouring cells. This is how the basic structure of our brain develops. In adults, new contact makes learning and memory possible. However, not all contact between cells is useful - most of it is dismantled again very quickly. Scientists at the Max Planck Institute for Neurobiology in Martinsried near Munich have now described a completely new technique with which nerve cells can evaluate the quality of the cells they contact in a very time- and energy-saving way. (Neuron, July 31, 2008)
Suckling infants trigger surges of trust hormone in mothers' brains
Researchers from the University of Warwick, in collaboration with other universities and institutes in Edinburgh, France and Italy, have for the first time been able to show exactly how, when a baby suckles at a mother's breast, it starts a chain of events that leads to surges of the "trust" hormone oxytocin being released in their mothers' brains.
Brain cancer study: Magnitude of post-vaccine immune response linked to clinical outcomes
Researchers conducting a clinical trial of a dendritic cell vaccine designed to fight malignant brain tumors called glioblastoma multiforme (GBM) have found a correlation between the "intensity" of a patient's immune response and clinical outcome, according to an article in the July 15 issue of the journal Cancer Research.
Cancer drug shows promise against graft vs. host disease
A new University of Michigan study in mice suggests that a drug recently approved to fight cancer tumors is also able to reduce the effects of graft-versus-host disease, a common and sometimes fatal complication for people who have had bone marrow transplants.

News discussion:

Medicine & Health news